An alternative could be other epigenetic modifications such as hypomethylation of the SOX4 gene, as exemplified by hypomethylated Claudin4, Lipocalin2, and S100A4, which accounts for their overexpression in pancreatic cancers [53]. This evidence concerns the gene SOX4 and pancreatic neoplasm.